Skip to main content

Table 5 Hematologic and non-hematologic toxicity (NCI-CTC version 3.0)

From: Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma

Toxicity

NCI-CTC Grade (n = 32)

  

0

1

2

3

4

  

No.

(%)

No.

(%)

No.

(%)

No.

(%)

No.

(%)

Hematologic

 

Leukocytopenia

4

(12.5)

9

(28.1)

11

(34.4)

8

(25.0)

0

(0.0)

 

Neutropenia

5

(15.6)

3

(9.4)

7

(21.9)

10

(31.3)

7

(21.9)

 

Anemia

1

(3.1)

12

(37.5)

17

(53.1)

2

(6.3)

0

(0.0)

 

Thrombocytopenia

28

(87.5)

4

(12.5)

0

(0.0)

0

(0.0)

0

(0.0)

Non-hematologic

Neurology

Neuropathy

18

(56.3)

8

(25.0)

5

(15.6)

1

(3.1)

0

(0.0)

GI

Stomatitis

13

(40.6)

12

(37.5)

4

(12.5)

3

(9.4)

0

(0.0)

 

Anorexia

10

(31.3)

17

(53.1)

5

(15.6)

0

(0.0)

0

(0.0)

 

Nausea/Vomiting

16

(50.0)

16

(50.0)

0

(0.0)

0

(0.0)

0

(0.0)

 

Constipation

23

(71.9)

6

(18.8)

3

(9.4)

0

(0.0)

0

(0.0)

 

Diarrhea

24

(75.0)

7

(21.9)

1

(3.1)

0

(0.0

0

(0.0)

Hepatic

AST↑

27

(84.4)

4

(12.5)

1

(3.1)

0

(0.0)

0

(0.0)

 

ALT↑

29

(90.6)

3

(9.4)

0

(0.0)

0

(0.0)

0

(0.0)

 

Bilirubin↑

25

(78.1)

6

(18.8)

1

(3.1)

0

(0.0)

0

(0.0)

Renal

Creatinine↑

23

(71.9)

8

(25.0)

1

(3.1)

0

(0.0)

0

(0.0)

Dermatology

Alopecia

5

(15.6)

16

(50.0)

11

(34.4)

0

(0.0)

0

(0.0)

 

Rash

25

(78.1)

5

(15.6)

2

(6.3)

0

(0.0)

0

(0.0)

 

Itching

27

(84.4)

5

(15.6)

0

(0.0)

0

(0.0)

0

(0.0)

 

Hyperpigmentation

20

(62.5)

10

(31.3)

2

(6.3)

0

(0.0)

0

(0.0)

 

Nail change

24

(75.0)

3

(9.4)

4

(12.5)

1

(3.1)

0

(0.0)

 

Hand-foot syndrome

18

(56.3)

9

(28.1)

4

(12.5)

1

(3.1)

0

(0.0)

Others

Asthenia

8

(25.0)

16

(50.0)

6

(18.8)

2

(6.3)

0

(0.0)

 

Myalgia

23

(71.9)

8

(25.0)

1

(3.1)

0

(0.0)

0

(0.0)

 

Febrile neutropenia

30

(93.8)

0

(0.0)

0

(0.0)

2

(6.3)

0

(0.0)

 

Pneumonitis

30

(93.8)

1

(3.1)

0

(0.0)

1

(3.1)

0

(0.0)